help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Collier, C. D.
Right arrow Articles by Simons, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Collier, C. D.
Right arrow Articles by Simons, S. S., Jr

Molecular Endocrinology, Vol 10, 463-476, Copyright © 1996 by Endocrine Society


ARTICLES

A negative tyrosine aminotransferase gene element that blocks glucocorticoid modulatory element-regulated modulation of glucocorticoid-induced gene expression

CD Collier, H Oshima and SS Simons Jr
Steroid Hormones Section, National Institute of Diabetes and Digestive and Kidney Diseases@Laboratory of Molecular and Cellular Biology, National Institute of Health, Bethesda, Maryland 20892, USA.

Tyrosine aminotransferase (TAT) is the prototypic steroid-inducible gene. Recently, we have found that the modulation of TAT induction properties is reproduced by a novel cis-acting TAT gene element, the glucocorticoid modulatory element (GME). This GME lies about 1 kb upstream of the glucocorticoid response elements (GREs) of the TAT gene and binds a heterooligomer of two recently defined proteins. We now report the existence of an additional TAT gene element between the GME and the GREs that blocks the action of the GME and thus prevents the left shift in the glucocorticoid dose-response curve caused by the GME. This negative element has the properties of a silencer because its activity is relatively position- and orientation-independent. The interaction appears to be stoichiometric in that the effects of a single negative element can be overcome by a second GME. This negative element also has an intrinsic inhibitory activity in the absence of the GME. The majority of the negative element activity could be elicited by a 56-bp sequence between -3105 and -3050 bp of the TAT gene. Multiple, clustered mutations of this sequence reduced, but did not eliminate, the negative activity. Further efforts to restrict the negative element were unsuccessful, suggesting that multiple sequences are required for full activity. High affinity, sequence-specific binding of a trans- acting factor(s) was observed in gel shift assays. This binding was half-maximally competed by a 4.4-fold excess of nonradioactive probe and was very stable once formed (delta H [symbol: see text] dissoc. = 32 kcal/mol), suggesting that low concentrations of a high affinity binding protein(s) exist in nuclear extracts. Further support for this conclusion came from the observation that cotransfection of a plasmid containing multiple copies of the 56-bp negative element was able to relieve the negation of GME activity in a GME-56-bp-GRE reporter construct. These data directly support the role of a trans-acting factor(s) in binding to the 56-bp negative element and blocking GME activity. Collectively, these data suggest that glucocorticoid induction of TAT gene expression is subject to multiple levels of control by several new cis-acting elements and thus is much more complex than previously appreciated.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
B. T. Vander Kooi, H. Onuma, J. K. Oeser, C. A. Svitek, S. R. Allen, C. W. Vander Kooi, W. J. Chazin, and R. M. O'Brien
The Glucose-6-Phosphatase Catalytic Subunit Gene Promoter Contains Both Positive and Negative Glucocorticoid Response Elements
Mol. Endocrinol., December 1, 2005; 19(12): 3001 - 3022.
[Abstract] [Full Text] [PDF]


Home page
J HeredHome page
S. R. Leib, T. C. McGuire, and D. J. Prieur
Comparison of the Tyrosine Aminotransferase cDNA and Genomic DNA Sequences of Normal Mink and Mink Affected with Tyrosinemia Type II
J. Hered., July 1, 2005; 96(4): 302 - 309.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. L. Surdo, M. J. Bottomley, M. Sattler, and K. Scheffzek
Crystal Structure and Nuclear Magnetic Resonance Analyses of the SAND Domain from Glucocorticoid Modulatory Element Binding Protein-1 Reveals Deoxyribonucleic Acid and Zinc Binding Regions
Mol. Endocrinol., July 1, 2003; 17(7): 1283 - 1295.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Chen, S. Kaul, and S. S. Simons Jr.
Structure/Activity Elements of the Multifunctional Protein, GMEB-1. CHARACTERIZATION OF DOMAINS RELEVANT FOR THE MODULATION OF GLUCOCORTICOID RECEPTOR TRANSACTIVATION PROPERTIES
J. Biol. Chem., June 7, 2002; 277(24): 22053 - 22062.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Kaul, J. A. Blackford Jr., S. Cho, and S. S. Simons Jr.
Ubc9 Is a Novel Modulator of the Induction Properties of Glucocorticoid Receptors
J. Biol. Chem., April 5, 2002; 277(15): 12541 - 12549.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Kaul, J. A. Blackford Jr., J. Chen, V. V. Ogryzko, and S. S. Simons Jr.
Properties of the Glucocorticoid Modulatory Element Binding Proteins GMEB-1 and -2: Potential New Modifiers of Glucocorticoid Receptor Transactivation and Members of the Family of KDWK Proteins
Mol. Endocrinol., July 1, 2000; 14(7): 1010 - 1027.
[Abstract] [Full Text]


Home page
Nucleic Acids ResHome page
H. Zeng, S. Kaul, and S. S. Simons
Genomic organization of human GMEB-1 and rat GMEB-2: structural conservation of two multifunctional proteins
Nucleic Acids Res., April 15, 2000; 28(8): 1819 - 1829.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Szapary, Y. Huang, and S. S. Simons Jr.
Opposing Effects of Corepressor and Coactivators in Determining the Dose-Response Curve of Agonists, and Residual Agonist Activity of Antagonists, for Glucocorticoid Receptor-Regulated Gene Expression
Mol. Endocrinol., December 1, 1999; 13(12): 2108 - 2121.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. Zeng, D. A. Jackson, H. Oshima, and S. S. Simons Jr.
Cloning and Characterization of a Novel Binding Factor (GMEB-2) of the Glucocorticoid Modulatory Element
J. Biol. Chem., July 10, 1998; 273(28): 17756 - 17762.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. J. Modarress, J. Opoku, M. Xu, N. J. Sarlis, and S. S. Simons Jr.
Steroid-induced Conformational Changes at Ends of the Hormone-binding Domain in the Rat Glucocorticoid Receptor Are Independent of Agonist Versus Antagonist Activity
J. Biol. Chem., September 19, 1997; 272(38): 23986 - 23994.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Chen, N. J. Sarlis, and S. S. Simons Jr.
Evidence for a Common Step in Three Different Processes for Modulating the Kinetic Properties of Glucocorticoid Receptor-induced Gene Transcription
J. Biol. Chem., September 22, 2000; 275(39): 30106 - 30117.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society